— Know what they know.
Not Investment Advice
Also trades as: SRZNW (NASDAQ) · $vol 0M

SRZN NASDAQ

Surrozen, Inc.
1W: +17.5% 1M: -0.4% 3M: +53.8% YTD: +37.0% 1Y: +114.8% 3Y: +329.8% 5Y: -67.2%
$29.53
+2.25 (+8.25%)
 
Weekly Expected Move ±14.5%
$18 $22 $25 $29 $33
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $220.8M mcap · 3M float · 13.92% daily turnover · Short 66% of daily vol
Credit Risk of going bust: higher than 69% of companies Debt: 2.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.18 (down 99.4%), Surrozen, Inc. would be worth roughly what it owes.
Total debt $6.3M against a stock market value of $220.8M.
Distance to default 3.46 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.2M (short-term plus half of long-term), stock volatility 109.1%; Altman Z'' -31.35. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$99M +103.7% ▲
5Y CAGR: +9.7%
Total Liabilities
$286M +310.2% ▲
5Y CAGR: +81.0%
Shareholders Equity
-$188M -778.2% ▼
Cash & Investments
$89M +158.2% ▲
5Y CAGR: +12.7%
Total Debt
$7M -21.6% ▼
5Y CAGR: -7.1%
Net Debt
-$83M -216.5% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$33M$25M$36M$35M$89M
Short-Term Investments$69M$51M$0$0$0
Cash & ST Investments$102M$76M$36M$35M$89M
Net Receivables$0$2M$2M$3M$208K
Inventory$0$0$0$0$0
Other Current Assets$0$756K$580K$671K$2M
Total Current Assets$105M$81M$41M$39M$92M
Property, Plant & Equip.$9M$7M$4M$8M$6M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$22M$0$688K$0$688K
Other Non-Current Assets$954K$1M$402K$1M$46K
Total Non-Current Assets$32M$8M$5M$10M$7M
Total Assets$137M$89M$46M$48M$99M
— Liabilities —
Accounts Payable$3M$658K$525K$306K$728K
Short-Term Debt$0$0$0$0$1M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$589K$581K$292K$191K$8M
Total Current Liabilities$14M$10M$7M$7M$10M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$8M$326K$115K$56M$271M
Total Non-Current Liabilities$14M$4M$997K$63M$277M
Total Liabilities$27M$13M$8M$70M$286M
— Equity —
Common Stock$4K$0$0$0$1K
Retained Earnings-$143M-$179M-$222M-$285M-$527M
Accumulated OCI-$119K-$241K$0$0$0
Total Stockholders Equity$110M$76M$38M-$21M-$188M
Total Liabilities & Equity$137M$89M$46M$48M$99M
— Key Metrics —
Total Debt$8M$6M$3M$8M$7M
Net Debt-$25M-$19M-$33M-$26M-$83M
Total Investments$90M$51M$688K$0$688K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms